791 related articles for article (PubMed ID: 10727588)
1. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
[TBL] [Abstract][Full Text] [Related]
2. Virologic characteristics of subclinical and symptomatic genital herpes infections.
Wald A; Zeh J; Selke S; Ashley RL; Corey L
N Engl J Med; 1995 Sep; 333(12):770-5. PubMed ID: 7643884
[TBL] [Abstract][Full Text] [Related]
3. Genital shedding of herpes simplex virus among men.
Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
[TBL] [Abstract][Full Text] [Related]
4. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
5. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
Kim HN; Meier A; Huang ML; Kuntz S; Selke S; Celum C; Corey L; Wald A
J Infect Dis; 2006 Aug; 194(4):420-7. PubMed ID: 16845624
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
Krone MR; Wald A; Tabet SR; Paradise M; Corey L; Celum CL
Clin Infect Dis; 2000 Feb; 30(2):261-7. PubMed ID: 10671325
[TBL] [Abstract][Full Text] [Related]
7. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
8. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
9. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
10. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
[TBL] [Abstract][Full Text] [Related]
11. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.
Tronstein E; Johnston C; Huang ML; Selke S; Magaret A; Warren T; Corey L; Wald A
JAMA; 2011 Apr; 305(14):1441-9. PubMed ID: 21486977
[TBL] [Abstract][Full Text] [Related]
12. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.
Lafferty WE; Coombs RW; Benedetti J; Critchlow C; Corey L
N Engl J Med; 1987 Jun; 316(23):1444-9. PubMed ID: 3033506
[TBL] [Abstract][Full Text] [Related]
13. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
14. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures.
Koutsky LA; Stevens CE; Holmes KK; Ashley RL; Kiviat NB; Critchlow CW; Corey L
N Engl J Med; 1992 Jun; 326(23):1533-9. PubMed ID: 1315930
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
Langenberg AG; Corey L; Ashley RL; Leong WP; Straus SE
N Engl J Med; 1999 Nov; 341(19):1432-8. PubMed ID: 10547406
[TBL] [Abstract][Full Text] [Related]
16. The acquisition of herpes simplex virus during pregnancy.
Brown ZA; Selke S; Zeh J; Kopelman J; Maslow A; Ashley RL; Watts DH; Berry S; Herd M; Corey L
N Engl J Med; 1997 Aug; 337(8):509-15. PubMed ID: 9262493
[TBL] [Abstract][Full Text] [Related]
17. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
Bourne N; Milligan GN; Stanberry LR; Stegall R; Pyles RB
J Infect Dis; 2005 Dec; 192(12):2117-23. PubMed ID: 16288376
[TBL] [Abstract][Full Text] [Related]
18. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.
Cherpes TL; Melan MA; Kant JA; Cosentino LA; Meyn LA; Hillier SL
Clin Infect Dis; 2005 May; 40(10):1422-8. PubMed ID: 15844064
[TBL] [Abstract][Full Text] [Related]
19. Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition.
Ramchandani M; Selke S; Magaret A; Barnum G; Huang MW; Corey L; Wald A
Sex Transm Infect; 2018 Dec; 94(8):568-570. PubMed ID: 29175899
[TBL] [Abstract][Full Text] [Related]
20. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes.
Slomka MJ; Emery L; Munday PE; Moulsdale M; Brown DW
J Med Virol; 1998 Jun; 55(2):177-83. PubMed ID: 9598940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
